ISRCTN94954912已完成不适用
Retrospective study on mannitol-assisted prophylaxis and treatment for acute promyelocytic leukemia
First Affiliated Hospital of Harbin Medical University (China)0 个研究点目标入组 100 人开始时间: 2014年1月20日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Any age APL patients, with either risks of central nervous system (CNS) relapse or already diagnosed with CNS relapse
- •2. Patients agreed to receive the prophylaxis or treatment
排除标准
- •1. Previous history of severe cardiovascular disease (coronary arterial disease, stroke, etc)
- •2. Severe chronic disease with poor prognosis (liver disease, kidney disease, etc)
- •3. Illegal drug use or chronic alcoholism
- •4. Physical limitations, mental or intellectual disabilities
- •5. Any condition that may affect the development of this trial
研究者
相似试验
已完成
不适用
Comparison of effect of Mannitol and 3% saline on cerebral hemodynamics of head injury patientsCTRI/2018/05/013830ONE20
招募中
3 期
The effect of preoperative intravenous mannitol injection in reducing acute kidney injury following percutaneous nephrolithotomyIRCT20200110046073N1Iran University of Medical Sciences150
进行中（未招募）
不适用
ong Term Administration of Inahled Mannitol in Cystic Fibrosis - A Safety and Efficacy StudyCystic FibrosisEUCTR2008-002740-42-DEPharmaxis Pharmaceuticals Limited300
进行中（未招募）
1 期
ong Term Administration of Inahled Mannitol in Cystic Fibrosis - A Safety and Efficacy StudyMedDRA version: 9.1Level: LLTClassification code 10011762Term: Cystic fibrosisCystic FibrosisEUCTR2008-002740-42-FRPharmaxis Pharmaceuticals Limited318
进行中（未招募）
不适用
ong Term Administration of Inahled Mannitol in Cystic Fibrosis - A Safety and Efficacy StudyMedDRA version: 9.1Level: LLTClassification code 10011762Term: Cystic fibrosisCystic FibrosisEUCTR2008-002740-42-BEPharmaxis Pharmaceuticals Limited300